Corrigendum to "Discovery of a novel Fam20C inhibitor for treatment of triple-negative breast cancer" [Int. J. Biol. Macromol. 286(2024) 138398].

Int J Biol Macromol

Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China. Electronic address:

Published: February 2025

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijbiomac.2025.141303DOI Listing

Publication Analysis

Top Keywords

corrigendum "discovery
4
"discovery novel
4
novel fam20c
4
fam20c inhibitor
4
inhibitor treatment
4
treatment triple-negative
4
triple-negative breast
4
breast cancer"
4
cancer" [int
4
[int macromol
4

Similar Publications

Corrigendum to "Discovery of 2,4-Quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations"[Eur. J. Med. Chem. 287 (2025) 117293].

Eur J Med Chem

February 2025

School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, 1 Xiangshanzhi Road, Hangzhou, 310024, China; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai, 201203, China; University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing, 110039, China; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, 264117, China. Electronic address:

View Article and Find Full Text PDF

Corrigendum to "Discovery of a novel Fam20C inhibitor for treatment of triple-negative breast cancer" [Int. J. Biol. Macromol. 286(2024) 138398].

Int J Biol Macromol

February 2025

Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China. Electronic address:

View Article and Find Full Text PDF

Corrigendum: D-dencichine regulates thrombopoiesis by promoting megakaryocyte adhesion, migration and proplatelet formation.

Front Pharmacol

January 2025

Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

[This corrects the article DOI: 10.3389/fphar.2018.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!